This protocol is judged by an institutional evaluate board, an unbiased group that assessments any clinical trials involving individuals. If a study requires a Schedule I drug, after the board approves the protocol as ethical, the researchers really have to apply for an investigational new drug (IND) amount within the FDA.Though the protocols nece